UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report  (Date of earliest event reported):   February 1, 2005

_________________

CRYOLIFE, INC.
(Exact name of registrant as specified in its charter)

_________________

FLORIDA 1-13165 59-2417093
(State or Other Jurisdiction
      of Incorporation) 		(Commission File Number)   (IRS Employer
Identification No.)

1655 ROBERTS BOULEVARD, N.W., KENNESAW, GEORGIA 30144
(Address of principal executive office) (zip code)

Registrant’s telephone number, including area code:   (770) 419-3355

_____________________________________________________________________
(Former name or former address, if changed since last report)

_________________

        Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01   Other Events.

On February 1, 2005, CryoLife, Inc. (“CryoLife”) issued a press release announcing that it received accreditation from the American Association of Tissue Banks (AATB). CryoLife hereby incorporates by reference herein the information set forth in its Press Release dated February 1, 2005, a copy of which is attached hereto as Exhibit 99.1.

Item 9.01   Financial Statements and Exhibits.

        (a)        Financial Statements.

        (b)        Pro Forma Financial Information.

        (c)        Exhibits.

  Exhibit Number Description
     
  99.1 Press Release dated February 1, 2005


2

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, CryoLife has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  CRYOLIFE, INC.
   
Date:   February 1, 2005 By:  /s/ D. A. Lee
Name: D. Ashley Lee
Title: Executive Vice President, Chief
Operating Officer and Chief Financial
Officer

3

EXHIBIT INDEX


Exhibit Number Description
   
99.1 Press Release dated February 1, 2005